IRIS
BREVETTI, GREGORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.732
AS - Asia 1.669
EU - Europa 1.306
SA - Sud America 195
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.677
SG - Singapore 827
RU - Federazione Russa 587
CN - Cina 306
VN - Vietnam 282
BR - Brasile 155
UA - Ucraina 149
DE - Germania 115
IT - Italia 108
HK - Hong Kong 105
FR - Francia 82
FI - Finlandia 72
NL - Olanda 52
GB - Regno Unito 40
SE - Svezia 37
CA - Canada 29
IN - India 25
BD - Bangladesh 19
IE - Irlanda 19
JP - Giappone 19
AR - Argentina 17
MX - Messico 16
PH - Filippine 12
PL - Polonia 11
IQ - Iraq 10
AT - Austria 9
ES - Italia 9
ZA - Sudafrica 9
CI - Costa d'Avorio 7
ID - Indonesia 7
TR - Turchia 7
EC - Ecuador 6
TH - Thailandia 6
AZ - Azerbaigian 5
IR - Iran 5
PK - Pakistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CZ - Repubblica Ceca 3
HN - Honduras 3
JO - Giordania 3
LT - Lituania 3
LV - Lettonia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
PS - Palestinian Territory 2
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SD - Sudan 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.937
Salva come PNG Salva come JPEG
Città #
Singapore 386
Chandler 199
San Jose 183
Moscow 167
Jacksonville 164
Hong Kong 97
Beijing 95
Ashburn 80
Santa Clara 78
Ho Chi Minh City 74
The Dalles 64
Hanoi 63
Princeton 52
Los Angeles 48
Lauterbourg 47
Amsterdam 46
Boston 46
Millbury 40
Wilmington 34
Munich 31
Nanjing 30
Buffalo 27
Dallas 27
New York 18
Houston 17
Da Nang 15
Boydton 14
Frankfurt am Main 14
Tokyo 14
Turku 13
São Paulo 12
Boardman 11
Nanchang 11
Ottawa 11
Warsaw 10
Kronberg 9
Naples 9
Biên Hòa 8
Brooklyn 8
Falls Church 8
Haiphong 8
Hebei 8
Tianjin 8
Campobasso 7
Chennai 7
Chicago 7
Hải Dương 7
Redondo Beach 7
Toronto 7
Atlanta 6
Falkenstein 6
Hefei 6
Helsinki 6
Mexico City 6
Montreal 6
Norwalk 6
Nuremberg 6
Orem 6
Rio de Janeiro 6
Baghdad 5
Baku 5
Can Tho 5
Johannesburg 5
Kunming 5
Napoli 5
Seattle 5
Shenyang 5
Bangkok 4
Belo Horizonte 4
Campinas 4
Denver 4
Jiaxing 4
Orange 4
Phoenix 4
Querétaro 4
Vienna 4
Betim 3
Changsha 3
Curitiba 3
Des Moines 3
Dhaka 3
Hangzhou 3
Jakarta 3
London 3
Mumbai 3
New Delhi 3
Salt Lake City 3
San Mateo 3
San Miguel de Tucumán 3
Stockholm 3
São Gonçalo 3
Tashkent 3
Tân Tiến 3
Amman 2
Annapolis 2
Asunción 2
Augusta 2
Baltimore 2
Belford Roxo 2
Bexley 2
Totale 2.547
Salva come PNG Salva come JPEG
Nome #
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 151
Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease. 143
Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication 138
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. 136
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. 134
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 133
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. 130
Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 124
Cellular adhesion molecules and peripheral arterial disease 121
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification 121
Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 118
Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis 116
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index 115
Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. 110
Intermittent claudication in Italy. The Peripheral Arteriopathy and Cardiovascular Events (PACE) study 109
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. 109
Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number 108
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 108
Early vascular alterations in acromegaly 107
Peripheral arterial disease: the magnitude of the problem and its socioeconomic impact. 105
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease 104
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. 101
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 100
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. 99
Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease. 99
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb 97
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose-titration, multicenter study 91
Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease 89
EARLY VASCULAR ALTERATIONS IN ACROMEGALY 88
Carnitine-related alterations in patients with intermittent claudication. Indication for a focused carnitine therapy 87
Women and peripheral arterial disease: same disease, different issues 83
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count 83
EUROPEAN MULTICENTER STUDY ON PROPIONYL-L-CARNITINE IN INTERMITTENT CLAUDICATION 82
Intermittent claudication: an historical perspective 82
Intermittent claudication and endothelial dysfunction 81
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function 81
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? 80
Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication 79
Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermitent claudication 79
MUSCLE CARNITINE DEFICIENCY IN PATIENTS WITH SEVERE PERIPHERAL VASCULAR DISEASE 77
Intermittent Claudication. Pharmacoeconomic and Quality of life aspects of treatment 75
Microcirculation and tissue metabolism in peripheral arterial disase 74
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not with classic risk factors and atheroscloritic burden 73
High Levels of adhesion molecules are associated with impaired endothelium-mediated vasodilation in patients with peripheral arterial disease 66
Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. 66
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease 64
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 63
Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome. 61
Infrarenal abdominal aortic aneurysms 60
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 60
Metabolic syndrome and cardiovascolar risk prediction in peripheral arterial disease. 60
Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication. 50
Totale 4.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.209
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 3 36 0
2021/2022251 3 0 0 2 2 6 8 8 25 9 72 116
2022/2023452 58 57 8 45 37 44 52 29 61 46 12 3
2023/2024192 6 48 29 11 8 10 0 17 4 8 32 19
2024/20251.245 73 69 1 8 84 20 114 92 101 106 477 100
2025/20262.170 258 109 273 233 453 117 258 87 258 124 0 0
Totale 4.970